SPAC

After SPAC deal fell flat, Visiox acquired by fellow eye-focused biotech
Fierce Pharma
Mon, 08/19/24 - 11:24 am
Visiox Pharmaceuticals
SPAC
Ocuvex Therapeutics
M&A
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
Fri, 09/22/23 - 11:42 am
AbPro
IPOs
SPAC
NASDAQ
Device company HDL Therapeutics eyes public listing in $480m SPAC deal
Pharmaphorum
Mon, 08/14/23 - 10:20 am
Medtech
SPAC
HDL Therapeutics
NASDAQ
atherosclerotic plaques
HIV cell therapy startup Addimmune heads to Wall Street via blank-check merger
BioPharma Dive
Fri, 08/11/23 - 09:58 am
Addimmune
HIV
SPAC
South Korean biotech group spies US SPAC as route to Nasdaq
Fierce Biotech
Wed, 07/12/23 - 09:46 am
OSR Holdings
South Korea
SPAC
NASDAQ
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
The slow death of the medtech SPAC deal
EP Vantage
Mon, 02/6/23 - 10:31 am
devices
Medtech
SPAC
Seastar Medical
Docgo
Hims & Hers Health
Alpha Tau Medical
Prosomnus
Neurology startup merges with Wilbur Ross-backed SPAC
BioPharma Dive
Thu, 01/19/23 - 08:57 pm
Aprinoia Therapeutics
Wilbur Ross
SPAC
Alzheimer's disease
Cancer-focused Liminatus sets out to test SPAC waters
Fierce Biotech
Fri, 12/2/22 - 11:05 am
Liminatus Pharma
SPAC
Biotech startup Ocean pivots from IPO to SPAC merger
BioPharma Dive
Wed, 08/31/22 - 10:24 pm
Ocean Biomedical
IPOs
SPAC
M&A
Aesther Healthcare Acquisition Corp
NewAmsterdam Pharma to Merge With SPAC Frazier Lifesciences
Marketwatch
Mon, 07/25/22 - 10:49 am
NewAmsterdam Pharma
M&A
SPAC
Frazier Lifesciences
Four months after first intranasal flunks influenza test, Revelation's second-gen asset misses on efficacy
Endpoints
Mon, 07/25/22 - 10:45 am
Revlation Biosciences
SPAC
clinical trials
Flu
SPAC merger called off as company connected to ex-Purdue CEO decides to remain private
Endpoints
Mon, 06/13/22 - 09:47 pm
Blade Therapeutics
Purdue Pharma
SPAC
M&A
Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks
Fierce Biotech
Thu, 06/2/22 - 12:19 pm
Bristol Myers Squibb
Immatics
SPAC
immunotherapy
drug discovery
biobucks
Ex-Sanofi CEO backs first European biomanufacturing SPAC
Pharmaforum
Mon, 05/9/22 - 10:00 am
Sanofi
Gerard le Fur
SPAC
Europe
A medtech company's SPAC merger falls flat, missing on nine-figure valuation
Endpoints
Mon, 04/18/22 - 11:40 pm
Medtech
SPAC
Accelus
Integrity Impants
Akili plays the Spac game for $1bn
EP Vantage
Thu, 01/27/22 - 10:40 am
devices
Medtech
SPAC
Akili Interactive
Psychedelics biotech set to go public via SPAC — pushing IV form of psilocybin into PhI
Endpoints
Thu, 01/20/22 - 10:58 am
Eleusis
SPAC
psychedelic drugs
Sema4 Looks to M&A After Successful SPAC
Medical Devices and Diagnostics Industry
Wed, 01/19/22 - 11:12 pm
Sema4
OPKO Health
GeneDx
M&A
SPAC
Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane
Endpoints
Mon, 11/8/21 - 10:53 am
Mark Timney
SPAC
Blade Therapeutics
Purdue Pharma
Biotech Acquisition Company

Pages